Switching delivery formats can be an effective strategy to enhance the lifecycle of your drug. Gain insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.
An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
Ovine and caprine viruses risk contamination of research cell banks when using antibodies of ovine or caprine origin for clone selection. Learn about the in vitro adventitious virus test.
Learn about the ICH Q5A revision addressing viral safety of biotechnology products derived from cell lines of human or animal origin that was recently published for public comment.
Learn when and how to effectively plan your stability testing program, how to ensure the right assay selection, and how forced degradation/accelerated studies may fit into your overall plan.
The Cooperativity Program’s goal is to help ISG clients build and strengthen their in-house departments — medical writing or otherwise — to reach their utmost potential.
A successful technology transfer sets the stage for GMP production and opens the door to process performance qualification campaigns and licensure.
Using lipid nanoparticles (LNP) for drug delivery is a promising area of research. Discover the benefits of LNP delivery, the types of lipid nanoparticles, their safety for drug delivery, and more.
Learn more about inclusions for your total cost of ownership, calculations to consider for cGMP chemical supply chain TCO, and how one mid-size CDMO improved cGMP chemical supply by outsourcing.
Get the latest articles from Outsourced Pharma delivered to your inbox.